Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scherer

Showing results (371-380 of 388) with videos related to

Pageof 39
Sort By:
Vaccine|October 17, 2024
Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adultsVarun K Phadke, Daniel J Gromer, Paulina A Rebolledo, et al.
Molecular Neurobiology|May 27, 2023
The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD PathogenesisJennilee M Davidson, Sharlynn S L Wu, Stephanie L Rayner, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trialNadine Rouphael, Shahida Baqar, Michelle Dickey, et al.
Nature Biotechnology|August 28, 2012
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensFrank Wegmann, Kate H Gartlan, Ali M Harandi, et al.
The New England Journal of Medicine|June 8, 2022
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised PatientsErin M Scherer, Ahmed Babiker, Max W Adelman, et al.
Science Immunology|June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Ecology|September 15, 2010
General stabilizing effects of plant diversity on grassland productivity through population asynchrony and overyieldingA Hector, Y Hautier, P Saner, et al.
Frontiers in Public Health|December 10, 2021
Application of SARS-CoV-2 Serology to Address Public Health PrioritiesAmy C Sherman, Teresa Smith, Yerun Zhu, et al.
Cell Reports|September 27, 2025
IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylationGunjan Sharma, Martin Gutierrez, Anthony E Jones, et al.
Pageof 39

Showing results (371-380 of 388) with videos related to

Sort By:
Pageof 39
Vaccine|October 17, 2024
Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adultsVarun K Phadke, Daniel J Gromer, Paulina A Rebolledo, et al.
Molecular Neurobiology|May 27, 2023
The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD PathogenesisJennilee M Davidson, Sharlynn S L Wu, Stephanie L Rayner, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trialNadine Rouphael, Shahida Baqar, Michelle Dickey, et al.
Nature Biotechnology|August 28, 2012
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensFrank Wegmann, Kate H Gartlan, Ali M Harandi, et al.
The New England Journal of Medicine|June 8, 2022
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised PatientsErin M Scherer, Ahmed Babiker, Max W Adelman, et al.
Science Immunology|June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Ecology|September 15, 2010
General stabilizing effects of plant diversity on grassland productivity through population asynchrony and overyieldingA Hector, Y Hautier, P Saner, et al.
Frontiers in Public Health|December 10, 2021
Application of SARS-CoV-2 Serology to Address Public Health PrioritiesAmy C Sherman, Teresa Smith, Yerun Zhu, et al.
Cell Reports|September 27, 2025
IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylationGunjan Sharma, Martin Gutierrez, Anthony E Jones, et al.
Pageof 39